Global Bioenergies

Equities

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 11:35:00 2024-04-26 am EDT 5-day change 1st Jan Change
1.788 EUR +2.17% Intraday chart for Global Bioenergies -2.83% -11.49%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant MT
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Global Bioenergies Partners with Shell on More Focused Development of Low-carbon Road Fuels MT
Global Bioenergies SA Announces Board Changes CI
Global Bioenergies: financial visibility extended CF
Global Bioenergies Hires Chief Business Officer MT
Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer CI
Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant MT
Global Bioenergies: disappointment after half-year results CF
Global Bioenergies SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Global Bioenergies Launches Isonaturane® 16, Its Second Cosmetic Ingredient CI
Global markets live: Blackberry, Meta Platforms, Rivian, GM... Our Logo
Global Bioenergies: capital increase, share price falls CF
Global markets live: Airbus, Walmart, Meta, Home Depot... Our Logo
Global Bioenergies: research contract extended with Shell CF
Global Bioenergies, Shell Extend Renewable Road Fuels R&D Deal MT
Global Bioenergies Successfully Hits Milestone in Shell Collaboration and Signs Follow-On Agreement CI
Global Bioenergies: significant sales in 2022 CF
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Global Bioenergies Scales Up Production at Pomacle Commercial Unit MT
Global Bioenergies Announces the Successful Scale-Up of Production At Its Pomacle Commercial Unit CI
Shell Teams Up With Global Bioenergies to Develop Low-Carbon Road Fuels MT
Global Bioenergies Agrees Collaboration with Shell in the Development of Low Carbon Road Fuels CI
Global Bioenergies Renews Equity Line With Kepler Cheuvreux MT
Global Bioenergies Jumps 7% on Completion of Residual Wood Conversion Project MT
Chart Global Bioenergies
More charts
Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.788 EUR
Average target price
2.6 EUR
Spread / Average Target
+45.41%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALGBE Stock
  4. News Global Bioenergies
  5. Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant